Pipeline and products

At MucosaTec GmbH, we are working at full speed on new and innovative drugs against influenza. We are also further evolving our platform technology to ensure it can be applied to other viruses in the future.

Development pipeline

Drug candidates currently in development based on our adaptable platform technology:

MT-AntiFlu-001

The first candidate of our anti-influenza agent. Antiviral activity was demonstrated in vitro and manufacturing scale already exceeds laboratory scale.

Preclinical Validation
MT-AntiFlu-002

The second anti-influenza candidate with enhanced virus-binding properties. Manufacturing at laboratory scale for antiviral activity assessment in vitro is currently in progress.

Discovery